Cn1: Brief Assessment of Priority Symptoms in Hormone Refractory Prostate Cancer (Hrpca)

Illness perceptions and emotional well-being in men treated for localized prostate cancer

“…While the FACT-G was developed to evaluate peritreatment QOL, it has since shown good psychometric properties in studies of posttreatment survivors [35]. The FACT-G has also specifically demonstrated adequate reliability and validity in numerous QOL studies of men with PC (Cronbach's alphas ranged from 0.59 to 0.87) [36].…”

“…In each model, perceived stress was entered in Step 4, and a vector representing the interaction between the illness perception and perceived stress was entered in Step 5. A significant interaction term (at Pb.05) was used as criterion for a significant moderator effect [36]. This procedure was repeated to test interactions between illness perceptions and sexual function in predicting EWB.…”

Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054)

“…PCS, which is measured on a scale of 0-104. A further clinically relevant symptom index, the FACT advanced prostate symptom index (FAPSI-8) was also derived from eight items of the FACT-P, which is measured on a scale of 0-32 (Yount et al 2003). The FACT-P subscales scores are derived such that a higher score indicates greater well-being.…”

Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer

“…The FACT-P Grand Total Score includes the FACT-G and the PCS. The FACT Advanced Prostate Symptom Index (FAPSI) includes eight items from the FACT-P: pain (three items), fatigue, weight loss, urinary difficulties (two items) and concern about the condition becoming worse [35]. The current analysis included an examination of all domains of the FACT-G, FACT-P and the FAP-SI.…”